On December 6, 2019 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, reported that the Company plans to host an R&D Day on December 17, 2019 at 8am Eastern Time in New York City (Press release, Sangamo Therapeutics, DEC 6, 2019, View Source [SID1234552006]). Sangamo executives and scientists will provide updates across the Company’s clinical and preclinical pipeline of genomic medicine product candidates, offer perspective on clinical data being presented at the upcoming American Society of Hematology (ASH) (Free ASH Whitepaper) Annual Meeting, and provide an overview of the Company’s manufacturing capabilities to support clinical and commercial supply.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the R&D Day including audio and slides will be available on the Events and Presentations page of the Sangamo website. A replay of the event will be archived on the website.